Markets & Stocks
Stay informed about the latest developments and trends in the cannabis stock market with Business of Cannabis. Discover new investment opportunities, market analysis, and more in our stocks category.
Markets & Stocks · page 16
- Markets & Stocks
OCT Secures MHRA Approval For Clinical Trials, Cantourage Posts First Profits, & More From DanCann Pharma
Oxford Cannabinoid Technologies [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”OCTP.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] The London Stock Exchange listed pharmaceutical cannabis company announced yesterday that it has at last secured MHRA approval for its Phase 1 Clinical Trials for its lead compound.
- Markets & Stocks
Cannabis stocks tumble after SAFE Banking Act discussed in Senate hearing
Proactive Investors reports that numerous testimonies in favor of the SAFE Banking Act were not enough to push cannabis stocks higher on Thursday.
- Markets & Stocks
Kanabo Announces £2.74m In New Funding, Cellular Goods Stock Skyrockets Over 100%, & Creso Pharma Cleared To Acquire Health House
Cellular Goods [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”CBX.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] After publishing lacklustre financial figures last week, the cannabis cosmetics retailer has seen its share price catapult by nearly 180%, seeing its market capitalisation almost triple.
- Markets & Stocks
Cannabis industry paid $1.8b in excess taxes in 2022, refund checks anyone?
Maine lawmakers reject interstate cannabis commerce bill in committee Marijuana Moment reports that a bill that would have authorized Maine’s governor to enter into agreements with other legal cannabis states to allow interstate cannabis commerce has been rejected.
- Markets & Stocks
Akanda’s Stock Price Jumps On Revenue Increase, MGC Pharma Secures EU-GMP At Malta Facility, & Cellular Goods Reports Growing Revenues
Akanda [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”AKAN” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Akanda was one of a number of major European cannabis firms to release financial figures this week, days before announcing that it had secured a new ‘short-term’ $500k loan.
- Markets & Stocks
Twitter further eases US cannabis advertising rules, adds new markets
Twitter further eases US cannabis advertising rules, adds new markets Following recent updates to its policy that would finally allow for cannabis advertising on the platform, Twitter is further loosening its limits on cannabis industry advertising, reports MJ Biz Daily.
- Markets & Stocks
South West Brands Bought By Rival OTO For £6.2m, Deepverge Stock Falls 60%, & Yooma Wellness Expects Cease Trade Order
Deepverge [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”DVRG.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Deepverge, a biotech firm based in Dublin, has seen its stock freefall 60% since the start of the month after announcing that its prospective revenues would be ‘approximately 45-50%’ of previous estimates.
- Markets & Stocks
German Announcement Hits Stocks, Ananda Shares Skyrocket, & Futura Medical Launches Flagship Product In The UK
Last week’s announcement from the German Health Minister Dr Karl Lauterbach has seen the stock in a number of companies with significant operations in Germany take a hit.
- Markets & Stocks
Cantourage Sees Revenues ‘Almost Triple’, BAT Invests $10m In New CBD Joint Venture, & Love Hemp’s New Owner Targets IPO
Cantourage [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”HIGH.F” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] German-based medical cannabis operator Cantourage has seen its stock jump 22% this week after revealing a 95% increase in revenues in its preliminary Q1 results.
- Companies
European Cannabis Stocks Review: Intercure Breaks Israeli Records In 2022, Chill Brands Rises, & Akanda Could Face Delisting Again
InterCure [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”INCR” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] InterCure has continued its blistering run of financial performance after revealing another record quarter over the weekend, ‘solidifying (its) leading position’ over its Israeli competitors and sending its stock up over 20%.
- Companies
Halo Collective announces management cease trade order, TerrAscend eyes TSX listing,
HALO COLLECTIVE Halo Collective announces management cease trade order Halo Collective has not met its filing deadline for its audited annual financial statements, accompanying management’s discussion and analysis, and related CEO and CFO certificates for the financial year ended December 31, 2022, reports Benzinga.
- CBD Market
FDA’s failure to regulate the CBD industry is ‘disrupting public confidence’ in the agency
Cannabis Daily News STOCKS This will be a big test for the cannabis industry Currently, one of the biggest hurdles for multi-state cannabis companies today is that they can’t trade on a major stock exchange due to the U.S. ban on the drug, reports The Motley Fool.
